Anti-IgE Reference Antibody (ligelizumab)

Référence APR10470

Conditionnement : 100ug

Marque : Abcepta

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

Anti-IgE Reference Antibody (ligelizumab)

Recombinant Antibody

 
  •  - Anti-IgE Reference Antibody (ligelizumab) APR10470

    Anti-IgE Reference Antibody (ligelizumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 90%.

  •  - Anti-IgE Reference Antibody (ligelizumab) APR10470

    The purity of Anti-IgE Reference Antibody (ligelizumab) is more than 95%, determined by SEC-HPLC.

Anti-IgE Reference Antibody (ligelizumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 90%.

Product Information

Application
  • Applications Legend:
  • WB=Western Blot
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin-embedded Sections)
  • IHC-F=Immunohistochemistry (Frozen Sections)
  • IF=Immunofluorescence
  • FC=Flow Cytopmetry
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • E=ELISA
  • IP=Immunoprecipitation
  • DB=Dot Blot
  • CHIP=Chromatin Immunoprecipitation
  • FA=Fluorescence Assay
  • IEM=Immuno electron microscopy
  • EIA=Enzyme Immunoassay
E
Primary Accession P0DOX4
Reactivity Human
Clonality Monoclonal
Isotype IgG1
Calculated MW 145 KDa

Additional Information

Target/Specificity IgE
Endotoxin < 0.001EU/ µg,determined by LAL method.
Conjugation Unconjugated
Expression system CHO
Format Purified monoclonal antibody supplied in PBS, pH6.0, without preservative.This antibody is purified through a protein A column.

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information

Name IGE
Function Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins- secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed:20176268, PubMed:22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed:17576170, PubMed:20176268).
Cellular Location Secreted. Cell membrane
Research Areas
  • Primary Antibodies
  • Antibody Collections
  • Recombinant Antibodies
  • Therapeutics References